Cite
High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
MLA
Chen, Meng, et al. “High Circulating Insulin-like Growth Factor-1 Reduces the Risk of Renal Cell Carcinoma: A Mendelian Randomization Study.” Carcinogenesis, vol. 42, no. 6, June 2021, pp. 826–30. EBSCOhost, https://doi.org/10.1093/carcin/bgab031.
APA
Chen, M., Tsai, C.-W., Chang, W.-S., Xiong, G. Y., Xu, Y., Bau, D.-T., & Gu, J. (2021). High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study. Carcinogenesis, 42(6), 826–830. https://doi.org/10.1093/carcin/bgab031
Chicago
Chen, Meng, Chia-Wen Tsai, Wen-Shin Chang, Grace Y Xiong, Yifan Xu, Da-Tian Bau, and Jian Gu. 2021. “High Circulating Insulin-like Growth Factor-1 Reduces the Risk of Renal Cell Carcinoma: A Mendelian Randomization Study.” Carcinogenesis 42 (6): 826–30. doi:10.1093/carcin/bgab031.